This article was originally published in The Gray Sheet
Both the Senate and House Appropriations Committees clear FDA fiscal 2008 funding bills July 19. The Senate bill includes $243.3 million for the device center, about $3 million more than the president requested in February (1"The Gray Sheet" Feb. 12, 2007, p. 3). The House matched the administration's request with a $240.1 million appropriation to CDRH. The Senate committee approved total FDA appropriations of $1.76 billion, slightly more than the House's $1.69 billion. Agency spending will also likely include about $48.5 million in device user fees, though user fee reauthorization legislation is still awaiting the outcome of a House-Senate conference (2"The Gray Sheet" July 16, 2007, p. 4). The House appropriations bill includes language preventing FDA from allowing individuals with financial conflicts to participate in advisory panel meetings. The provision has been included in funding bills for the past two years but has always been removed or weakened before final passage...
You may also be interested in...
The House passed broad-based FDA legislation July 11 that includes a package to reauthorize the medical device user fee program
A molecular assay that helps evaluate the extent cancer might have spread from a breast tumor was recommended for approval by FDA's Immunology Devices Panel Nov. 16
No device-related warning letters were released by the US FDA the week of 31 March.